Rxivist logo

Bacterial metabolism rescues the inhibition of intestinal drug absorption by food and drug additives

By Ling Zou, Peter Spanogiannopoulos, Huan-Chieh Chien, Lindsey M Pieper, Wenlong Cai, Natalia Khuri, Joshua Pottel, Bianca Vora, Zhanglin Ni, Eleftheria Tsakalozou, Wenjun Zhang, Brian K Shoichet, Kathleen M. Giacomini, Peter J. Turnbaugh

Posted 28 Oct 2019
bioRxiv DOI: 10.1101/821132 (published DOI: 10.1073/pnas.1920483117)

Food and drugs contain diverse small molecule additives (excipients) with unclear impacts on human physiology. Here, we evaluate their potential impact on intestinal absorption, screening 136 unique compounds for inhibition of the key transporter OATP2B1. We identified and validated 24 potent OATP2B1 transport inhibitors, characterized by higher molecular weight and hydrophobicity compared to poor or non-inhibitors. OATP2B1 inhibitors were also enriched for dyes, including 8 azo (R−N=N−R′) dyes. Pharmacokinetic studies in mice confirmed that FD&C Red No. 40, a common azo dye excipient, inhibited drug absorption; however, the human gut microbiome inactivated azo dye excipients, producing metabolites that no longer inhibit OATP2B1 transport. These results support a beneficial role for the microbiome in limiting the unintended effects of food and drug additives in the intestine.

Download data

  • Downloaded 360 times
  • Download rankings, all-time:
    • Site-wide: 61,115 out of 118,130
    • In pharmacology and toxicology: 377 out of 1,029
  • Year to date:
    • Site-wide: 46,418 out of 118,130
  • Since beginning of last month:
    • Site-wide: 74,721 out of 118,130

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide


Sign up for the Rxivist weekly newsletter! (Click here for more details.)